ANALYSIS: With some local fund managers looking to allocate more capital to private assets, it’s only right that they tell us how much skin their portfolio managers have in the game.
ANALYSIS: The dual-listed healthcare and animal care company is trying to convince investors about its long-term growth drivers.
ANALYSIS: With its embrace of AI, the Canva which eventually goes public is likely to be a different company from the 2026 version.
ANALYSIS: A tech, law and government conference has brought the crucial choices New Zealand faces into stark light, as Microsoft’s CEO visits this week.
ANALYSIS: The Commerce Commission is taking forever to decide whether Mohawk Industries might be a wolf in sheep’s clothing.
ANALYSIS: Investors have lost millions and companies have collapsed, but medicinal cannabis players still see a bright future.
ANALYSIS: Their companies have performed spectacularly on ASX over the past year, and shares surged when shooting war started in Iran. A big sell-off, however, leaves a question mark over whether 2026 will be the ‘year of the drone’.
ANALYSIS: The US Government’s punishment of AI company Anthropic for resisting its war-fighting holds some key lessons for New Zealand.
ANALYSIS: A revamped offer from an unlisted property fund seeks to raise capital from new investors to help pay for the potential exits for older ones.
ANALYSIS: The well-known intangible assets specialist looks likely to be tipped into liquidation. Accusations are flying over what went wrong.